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ABSTRACT 
 
About 1% of people with hypertension develops hypertensive crisis over some point of life period. Report a case on 
malignant hypertension with grade II retinopathy and renal failure. A patient with a known case of hypertension for 
past 5 years was admitted with complaints of headache, orthopnoea, difficulty in breathing and an elevated BP of 
220/110 mm Hg and was diagnosed to have malignant hypertension. The patient was referred to ophthalmologist on 
the second day. The fundus examination showed grade II hypertensive retinopathy. On laboratory investigation 
serum creatinine and urea level was elevated, urine analysis showed moderate albuminuria, with decreased 
Glomerular filtration rate and patient was diagnosed to have stage 3 Chronic kidney disease. The patient was treated 
with a triple combination of Angiotensin Receptor Blocker (ARB) + Calcium channel blocker (CCB) + β blocker, 
diuretics, centrally acting antihypertensive, statin and antiplatelet agent. Blood pressure was subsided followed by 
gradual improvement in visual acuity. 
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Introduction 
 
Hypertension is defined as persistent elevation of 
arterial blood pressure.[1]It is considered as a major 
cause of mortality worldwide. Acute hypertension can 
lead to accelerated or malignant hypertension.[2]It 
occurs in about 1% of people with high blood 
pressure.[3]Malignant hypertension is defined as 
extremely high blood pressure (above 180/120 mmHg) 
which develops rapidly and can lead to targeted organ 
damage.[4]The systems primarily involved include 
central nervous system (brain and eyes), cardiovascular 
system, and renal system.[5,6] Patients diagnosed with 
malignant hypertension have severe hypertension with 
bilateral retinal haemorrhage and exudates (Figure 
No.1).[2,7]Uncontrolled high blood pressure leads to 
increase in intra glomerular pressure causing 
impairment of glomerular filtration which in turn lead 
to abnormal protein levels in urine(proteinuria) (Figure 
No.2).[8] 
_______________________________ 
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Case Report 
 
A 57 year old male patient was admitted in a tertiary 
care hospital in general medicine department with 
complaints of headache for past 10 days, not associated 
with vomiting episodes. He was also presented with 
orthopnoea and difficulty in breathing (grade III). 
Previous medical history shows that he has a known 
case of hypertension and was on regular medication of 
Amlodipine and Atenolol for past 5 years. On 
admission, blood pressure was found to be 
220/110mmHg. Physician advised to monitor blood 
pressure every 6th hourly on daily basis (given in table 
1) and was diagnosed with Malignant hypertension. 
Chest x-ray revealed cardiomegaly with increased 
bronchovascular markings and prominent aortic 
knuckle. ECG showed sinus bradycardia. ECHO 
cardiogram was done with findings of interventricular 
septal hypertrophy, grade I LV diastolic dysfunction 
and trivial mitral regurgitation. Ejection fraction was 
found to be 65%.Vital signs of temperature, pulse and 
respiratory rate was found to be normal. Other 
investigations are shown in table 2 and 3. 
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The patient was referred to ophthalmologist. On fundus 
analysis basic examination findings were: both eye disc 
was normal and showed grade II sclerosis of retinal 
arterioles, small retinal haemorrhages and arteriolar 
narrowing. Impression was grade II hypertensive 
retinopathy. USG abdomen showed increased renal 
cortical echoes. On laboratory investigation blood urea, 
serum creatinine levels were found to be 
elevated.Urinalysis showed presence of trace amount 
of albumin. Based on these examinations and GFR 
(shown in table 4) values, it was diagnosed as Stage 3 
Chronic kidney disease.  
 
  
Fig1: Hypertensive retinopathy[10]
                                     
Fig 2:Hypertensive renal damage[11] 
Daily blood pressure chart 
Table 1: Blood Pressure Chart 
 
Table 2: Laboratory Investigation Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1:Urinalysis 
DAILY BLOOD PRESSURE CHART 
Date & Time 25/1 26/1 27/1 28/1 29/1 30/1 31/1 1/2 
8.00AM 190/116 180/110 174/100 200/110 170/100 140/100 180/110 140/90 
2.00PM 180/100 180/108 172/100 180/110 160/100 140/110 140/100 140/100 
8.00PM 180/106 180/106 180/110 180/100 170/100 160/100 160/100 140/100 
LABORATORY INVESTIGATIONS 
SL.No. Lab test Patient value 
1 ESR 18mm/hr 
2 WBC 10.7 ×109/L 
3 Hgb 13.9g/dl 
4 HCT 40.2% 
5 RBC 4.69×1012/L 
6 MCV 85.9fL 
7 MCH 29.6pg 
8 MCHC 34.5g/dl 
9 PLT 246×109/L 
10 L% 22.3% 
11 M% 8.1% 
12 G% 69.6% 
13 RBS 84 mg/dl 
Urinalysis 
Colour: pale yellow                         Pus cells: 3-5/hpf 
Reaction: acidic      RBC: 0-1/hpf 
Albumin: (+)     Epithelial cells: 1-2/hpf 
Sugar: nil                     Cast/crystals: nil 
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Table 4: Kidney Function Test 
 
 
 
Table 5: Input Output Chart 
 
 
 
 
Treatment given to the patient 
The patient was on Amlodipine and Atenolol for 
past 5 years. Then the patient  referredto a private 
hospital before one week with complaints of 
giddiness and vomiting and he was prescribed with 
T.Losartan, T.Metoprolol, and T.Alprazolam. On 
admission the patient was started with a triple 
combination of Metoprolol+ 
Clinidipine+Telmisartan, InjTorsemide, Tablet 
Moxonidine, Tablet Atorvastatin+Clopidogrel and 
Tablet Paracetamol. On fourth day serum 
creatinine was found to be elevated. It was 
identified that Telmisartan was the cause 
thereafter, it was discontinued. On discharge 
patient was prescribed with T.Moxonidine, 
T.Clonazepam, T.Atorvastatin+Clopidogrel, 
T.Clinidipine, T.Paracetamol, T.Torsemide, 
Capsule Alpha D3. 
 
Discussion 
 
The patient was on Amlodipine +Atenolol for past 
5years. One week before getting admitted on this 
hospital, he referred to a private hospital with 
complaints of giddiness and vomiting .He was 
prescribed with T.Losartan, T.Metoprolol, and 
T.Alprazolam. But the past medication taken by 
the patient was not effective in lowering the blood 
pressure.Blood pressure control was attained only 
after the triple combination of Telmisartan 
(Angiotensin Receptor Blocker) +Metoprolol 
(βBlocker)+Clinidipine (Calcium Channel 
Blocker) along with centrally acting 
antihypertensiveMoxonidine and Injection 
Torsemide was given. The patient was diagnosed 
as Stage 3 Chronic Kidney Disease with a 
creatinine level of 2.8mg/dl (GFR-33.7ml/min). 
After the patient was started with triple therapy, 
the serum creatinine level was elevated to 
3.9mg/dl. During the ward rounds, Clinical 
Pharmacist found that the serum creatinine was 
further elevated due to Telmisartan containing 
triple combination. Some evidence from the 
previous studies suggests that the Telmisartan can 
cause increase in serum creatinine.[9] Hence, 
Telmisartan was discontinued and prescription was 
changed to double combination of 
Metoprolol+Clinidipine. Blood pressure was 
controlled with the medications. Patient was 
prescribed with atorvastatin and clopidogrel as per 
standard treatment guidelines for management of 
cardiovascular risk in CKD.[9] But in this case 
patient’s bleeding time and clotting time was not 
checked and lipid profile was not done.  
 
Abbreviations 
 
 BP:Blood Pressure 
 ARB:Angiotensin Receptor Blocker 
 CCB:Calcium Channel Blocker 
 ECG:Electro Cardio Gram 
 ECHO:Echocardiogram 
 LV:Left Ventricle 
 USG:Ultra Sono Gram 
 GFR:Glomerular Filtration Rate 
 CKD:Chronic Kidney Disease 
 ACE:Angiotensin Converting Enzyme 
  
KIDNEY FUNCTION TEST 
SL.No. Investigation 23/1 26/1 31/1 
1 S. Creatinine 2.8mg/dl 3.9mg/dl 2.9 mg/dl 
2 B. Urea 54mg/dl 87mg/dl 65mg/dl 
3 GFR 33.75 ml/min 24.23 ml/min 32.6 ml/min 
INPUT/OUTPUT CHART 
Date 25/1 26/1 27/1 28/1 29/1 30/1 31/1 1/2 
Input (ml) 1100 1750 1200 1400 1400 1200 1400 1300 
Output (ml) 1050 2750 1700 1300 1300 1100 1350 1500 
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Conclusion 
 
In this case, we found that Telmisartan can lead to 
increase in serum creatinine in CKD patients. So we 
insist the health care providers that serum creatinine 
should be closely monitored while on therapy with 
ARB/ACE inhibitors in CKD patients. According to 
the patients 
We suggest the importance of checking relevant 
laboratory parameters. Drugs have to be given in 
accordance with the diagnosis and laboratory values. 
And it is necessary to have routine check-up of 
laboratory values to assess the impact of certain drugs 
on the relevant parameters.  
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